Significance of HER2 in Microinvasive Breast Carcinoma.

Zhang, Huina; Moisini, Ioana; Turner, Bradley M; Wang, Xi; Dhakal, Ajay; Yang, Qi; Kovar, Sierra; Schiffhauer, Linda M; Hicks, David G

Zhang, Huina; Moisini, Ioana; Turner, Bradley M; Wang, Xi; Dhakal, Ajay; Yang, Qi; Kovar, Sierra; Schiffhauer, Linda M; Hicks, David G.

Afiliação

Zhang H; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Moisini I; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Turner BM; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Wang X; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Dhakal A; Department of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY.
Yang Q; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Kovar S; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Schiffhauer LM; Department of Pathology, University of Rochester Medical Center, Rochester, NY.
Hicks DG; Department of Pathology, University of Rochester Medical Center, Rochester, NY.

Am J Clin Pathol ; 156(1): 155-165, 2021 06 17.

Article em En | MEDLINE | ID: mdl-33491064

Assuntos

Neoplasias da Mama/patologia; Carcinoma Intraductal não Infiltrante/patologia; Receptor ErbB-2/metabolismo; Adulto; Idoso; Feminino; Humanos; Pessoa de Meia-Idade

Palavras-chave

Breast; HER2; Microinvasive carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Intraductal não Infiltrante / Receptor ErbB-2 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google